GLPG
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Jul 2024)
What this means for you
This application is over — abandoned 01 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98094108
- Mark type
- Stylized text
- Filed
- 20 Jul 2023
- Published for opposition
- 03 Oct 2023
- Abandoned
- 01 Jul 2024
- Attorney of record
- Alexandra MacKay
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical substances and preparations for human use, namely, for the treatment of inflammatory diseases, autoinflammation diseases, autoimmune diseases, proliferative diseases, cancer, skin diseases, cardiovascular diseases, anti-infectives, hepatitis B virus, osteoarthritis, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma; biopharmaceutical substances and preparations for human use, namely, for the treatment of inflammatory diseases, autoinflammation diseases, autoimmune diseases, proliferative diseases, cancer, skin diseases, cardiovascular diseases, anti-infectives, hepatitis B virus, osteoarthritis, rheumatoid arthritis, atopic dermatitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma
- Class 042 — Scientific and technological services: medical and scientific research services; industrial research services in the field of assay development, target discovery and validation, drug development, chimeric antigen receptor T-cell therapy, and medicinal chemistry; pharmaceutical and biopharmaceutical research and development services; medical and scientific research, namely, the examination and testing of genes; development, laboratory analysis, and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis, and testing of medicaments; the development of clinical assays, cellular tests, testing kits, diagnostic kits, and companion diagnostics for evaluating pharmaceutical and biopharmaceutical products of others; development of computer databases in the medical, pharmaceutical and biopharmaceutical fields and gathering of data to populate those databases via collection of medical, pharmaceutical, biopharmaceutical research and clinical trial data; gene bank services for research purposes
- Class 044 — Medical, beauty and agricultural services: medical services; medical and pharmaceutical advisory and consultancy services; gene bank services
Owner
- Galapagos NV, Mechelen, BE
- Galapagos NV, Mechelen, BE
Prior registrations
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 28 Nov 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Nov 2023 — ASSIGNED TO EXAMINER
- 03 Oct 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Oct 2023 — PUBLISHED FOR OPPOSITION
- 13 Sept 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Aug 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Aug 2023 — ASSIGNED TO EXAMINER
- 20 Aug 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Jul 2023 — NEW APPLICATION ENTERED